|
|
Quarterly Results |
|
Bharat Immunological & Biological Corporation Ltd | Industry : Pharmaceuticals - Indian - Formulations | Chairman : Y K Gupta | Home : Govt of India | Book Value: -7.5352246 | BSE Code : 524663 | Market Cap: 131.09 | NSE Code : | P / E : 0 | |
| |
|
|
|
|
|
(Rs in Cr.) |
|
Type | 2Qtr | 1Qtr | 4Qtr | 3Qtr | Net Sales | 0.00 | 0.00 | 7.65 | 0.00 | Other Income | 0.16 | 0.10 | 0.49 | 0.10 | Total Income | 0.16 | 0.10 | 8.15 | 0.10 | Total Expenditure | 4.69 | 4.31 | 11.67 | 4.73 | Operating Profit | -4.52 | -4.21 | -3.53 | -4.62 | Interest | 2.09 | 1.72 | 2.06 | 1.67 | Gross Profit | -6.61 | -5.93 | -5.59 | -6.29 | Depreciation | 0.03 | 0.03 | 0.09 | 0.04 | Tax | 0.00 | 0.00 | 0.00 | 0.00 | Deferred Tax | -1.73 | -1.38 | -1.80 | -1.65 | Reported Profit After Tax | -4.92 | -4.59 | -3.88 | -4.68 |
|
|
|
|
|